Energetic Abnormalities in Heart Failure With Preserved Ejection Fraction
1 other identifier
observational
50
1 country
1
Brief Summary
Up to half of all patients with heart failure are found to have normal pumping function of the heart muscle, but show abnormalities in the way the heart muscle relaxes and fills with blood. These patients often have high blood pressure, and tend to have stiff arteries and stiff heart muscle. We wish to test the hypothesis that these patients have abnormal energy stores in their heart muscle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
February 24, 2008
CompletedFirst Posted
Study publicly available on registry
March 4, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedMarch 4, 2008
February 1, 2008
3.1 years
February 24, 2008
February 24, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Complete echocardiographic assessment to assess resting diastolic function
1 DAY
Assessment of resting large artery function
1 DAY
Multiple Gated Acquisition Scan
1 DAY
Cardiac Magnetic Resonance Spectroscopy
1 DAY
Metabolic Exercise Testing (VO2max)
1 DAY
Study Arms (2)
HfpEF
Patients with Heart Failure with preserved ejection fraction
Control
Healthy Volunteers
Eligibility Criteria
Heart Failure Clinic
You may qualify if:
- Clinical features consistent with heart failure
- LVEF ≥ 50%, with no evidence of significant valvular disease, no hypertrophic cardiomyopathy, and no evidence of pericardial constriction
- A peak VO2 \< 80% predicted, with a pattern of gas exchange on metabolic exercise testing indicating a cardiac cause for limitation
You may not qualify if:
- Objective evidence of lung disease on formal lung function testing
- Reversible myocardial ischaemia on contrast-enhanced myocardial stress
- Echocardiography, and evidence of exercise-induced mitral regurgitation
- Obesity (BMI \>35) or a locomotor cause for exercise limitation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Birminghamlead
- Heart of England NHS Trustcollaborator
- British Heart Foundationcollaborator
Study Sites (1)
University of Birmingham
Birmingham, B15 2TT, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Frenneaux, FRCP
University of Birmingham
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 24, 2008
First Posted
March 4, 2008
Study Start
March 1, 2006
Primary Completion
April 1, 2009
Study Completion
April 1, 2009
Last Updated
March 4, 2008
Record last verified: 2008-02